Sign Up to like & get
recommendations!
2
Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10061221
Abstract: Anti-CD3-epsilon (CD3e) monoclonal antibodies (mAbs) and CD3e immunotoxins (ITs) are promising targeted therapy options for various T-cell disorders. Despite significant advances in mAb and IT engineering, vascular leakage syndrome (VLS) remains a major dose-limiting toxicity…
read more here.
Keywords:
cd3e;
szap;
main driver;
cd3e mab ... See more keywords